In the ongoing debate surrounding opioid prescriptions for adolescents, a new study from the University of Alberta challenges the prevailing notion that these medications are the primary driver of the opioid crisis among young people. The research, led by Dr. Henry Li, an emergency physician and pediatric emergency medicine fellow, suggests that the pendulum may have swung too far in the direction of caution, and that a more nuanced approach to opioid prescribing for adolescents in pain is warranted.
The study, which analyzed population-level data from nearly 1.2 million emergency department visits by Alberta teens aged 12 to 17 between 2010 and 2020, found that opioid prescriptions decreased from 3.3% of visits in 2010 to 1.2% in 2020. Over the same period, the development of opioid-related harms in this age group rose from 0.15% to 0.28%. This increase is concerning, but the study authors argue that it does not necessarily indicate that emergency department opioid prescriptions are the main cause of the opioid epidemic among youth.
One of the key findings of the study is that the rise in opioid-related harms among teens is not directly linked to the number of opioid prescriptions. Instead, the authors suggest that the current opioid crisis among youth is driven by contaminants in the supply of illicit fentanyl, carfentanil, and other street drugs. This shift in the nature of the crisis, from overprescribing and aggressive marketing to doctors in the 1990s and early 2000s, has led to a different set of challenges for healthcare providers and policymakers.
Dr. Li, who has first-hand experience of the impact of the opioid crisis on the patients he serves, emphasizes the importance of balancing caution with the need to provide effective pain management for adolescents. "You feel this hesitancy about prescribing opioids because it's been drilled into us from the media that opioid prescriptions are why we have the opioid crisis," he says. "On every shift, we see how the opioid crisis is impacting the patients that we serve, and we really don't want to be contributing to that."
However, the study also highlights the need for a more nuanced approach to opioid prescribing for adolescents. While the numbers are small, the doubling of opioid-related harms among teens over a decade is a cause for concern. The authors argue that healthcare providers should not shy away from using opioids to treat adolescents in pain when other medications are not working, but should instead focus on identifying and addressing the root causes of the opioid crisis among youth.
In my opinion, this study raises important questions about the balance between caution and effectiveness in opioid prescribing for adolescents. While the findings suggest that emergency department opioid prescriptions may not be the primary driver of the opioid epidemic among youth, they also highlight the need for a more thoughtful and context-specific approach to pain management for young people. As healthcare providers and policymakers, we must continue to grapple with the complex interplay between pain relief, addiction risk, and the evolving nature of the opioid crisis.
One thing that immediately stands out is the shift in the nature of the opioid crisis among youth. While the overprescribing and aggressive marketing of opioids to doctors in the 1990s and early 2000s were significant factors in the initial wave of the crisis, the current crisis is driven by contaminants in the supply of illicit drugs. This raises a deeper question about the role of healthcare providers in addressing the root causes of the opioid crisis, rather than simply focusing on reducing opioid prescriptions. What this really suggests is that a comprehensive and multifaceted approach to opioid prescribing and pain management is needed, one that takes into account the unique challenges and vulnerabilities of adolescents.
